Don Bongino, newly-appointed FBI Deputy Director, was once diagnosed with Hodgkin's lymphoma diagnosis and even underwent surgery for a large tumor in his neck.

In the last two decades, the increased knowledge about the mechanisms underlying the process of malignant transformation and the improved techniques in DNA ...

Cambridge biotech Healx stands on the cusp of history after dosing the first patient with a rare and deadly cancer with a ...

Healx, an AI-enabled, clinical-stage biotech company dedicated to rare diseases, today announced the first patient has been dosed in INSPIRE-NF1, a Phase 2 trial evaluating the safety and efficacy of ...

“Melanoma is an invasive skin cancer, with a very high risk of death ... Discounting the numerous very early-stage melanomas (malignant moles in simple terms), which have been removed without any ...